Form D
View Original Filing
Notice of Exempt Offering of Securities
Item 1. Issuer's Identity
Name of Issuer:
CONTRAFECT CORP
Jurisdiction of Incorporation/Organization
DE
Year of Incorporation/Organization
2008
Item 2 Issuer Principal Place of Business and Contact Information
28 WELLS AVENUE
3RD FLOOR
YONKERS, NY 10701
Phone Number:
subscription required
Item 3. Related Persons
Name
ROBERT NOWINSKI, PH.D.
Address
subscription required
Relationship(s)
- EXECUTIVE OFFICER
- DIRECTOR
Clarification of Response
Item 3. Related Persons
Name
SOL BARER, PH.D.
Address
subscription required
Relationship(s)
Clarification of Response
Item 3. Related Persons
Name
SIR RICHARD SYKES, FRS
Address
subscription required
Relationship(s)
Clarification of Response
Item 3. Related Persons
Name
ISSAC BLECH
Address
subscription required
Relationship(s)
Clarification of Response
Item 3. Related Persons
Name
DAVID SCHEINBERG, M.D., PH.D.
Address
subscription required
Relationship(s)
Clarification of Response
Item 3. Related Persons
Name
CARY SUCOFF
Address
subscription required
Relationship(s)
Clarification of Response
Item 3. Related Persons
Name
SHENGDA ZAN
Address
subscription required
Relationship(s)
Clarification of Response
Item 3. Related Persons
Name
JULIA P. GREGORY
Address
subscription required
Relationship(s)
Clarification of Response
Item 3. Related Persons
Name
DAVID HUANG, M.D., PH.D
Address
subscription required
Relationship(s)
Clarification of Response
Item 3. Related Persons
Name
MICHAEL WITTEKIND, PH.D.
Address
subscription required
Relationship(s)
Clarification of Response
Item 4. Industry Group
BIOTECHNOLOGY
Item 5. Issuer Size
Revenue Range (for issuer not specifying "hedge" or "other investment" fund in Item 4 above)
DECLINE TO DISCLOSE
Item 6. Federal Exemptions and Exclusions Claimed
Item 7. Type of Filing
New Notice
Date of First Sale in this Offering:
06/18/2013
Item 8. Duration of Offering
Does the issuer intend this offering to last more than one year?
No
Item 9. Type(s) of Securities Offered
- Debt
- Option, Warrant or Other Right to Acquire Another Security
- Security to be Acquired Upon Exercise of Option, Warrant or Other Right to Acquire Security
Item 10. Business Combination Transaction
Is this offering being made in connection with a business combination
transaction, such as a merger, acquisition or exchange offer?
No
Clarification of Response
Item 11. Minimum Investment
Minimum Investment accepted from any outside investor
25000
Item 12. Sales Compensation
Recipient
MAXIM GROUP LLC
Recipient CRD Number
120708
(Associated) Broker or Dealer)
NONE
(Associated) Broker or Dealer CRD Number
NONE
Address
405 LEXINGTON AVENUE
NEW YORK, NY 10174
States of Solicitation
Item 13. Offering and Sales Amounts
Total Offering Amount
10000000
Total Amount Sold
9997650
Total Remaining to be Sold
2350
Clarification of Response
Item 14. Investors
Securities in the offering have been or may be sold to persons
who do not qualify as accredited investors,
Number of non-accredited investors who already have invested in the offering:
Total number of investors who already have invested in the offering:
94
Item 15. Sales Commissions and Finders' Fees Expenses
Sales Commissions:
934765.0
Finders' Fees
0.0
Clarification of Response
Item 16. Use of Proceeds
Provide the amount of the gross proceeds of the offering
that has been or is proposed to be used for payments to any of the persons required
to be named as executive officers,directors or promoters in response to Item 3 above.
0.0 Is an estimate
Clarification of Response
Signature and Submission
Issuer Name
CONTRAFECT CORP
Issuer Signature
/S/ ROBERT NOWINSKI
Signer Name
ROBERT NOWINSKI, PH.D.
Signer Title
CHIEF EXECUTIVE OFFICER
Signature Date
06/27/2013